Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – a combination of 2 nucleoside analog HIV-1 reverse transcriptase inhibitors and 1 non-nucleoside HIV-1 reverse transcriptase inhibitor commonly used to treat infection by the human immunodeficiency virus (HIV). FDA approved uses: Atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents to treat […]